9OE5 | pdb_00009oe5

Zebrafish Abcb4 in IF-Medium conformation in the presence of Elacridar (ELA-IF-Medium)


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.16 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation 3D Report Full Report

Validation slider image for 9OE5

This is version 1.1 of the entry. See complete history

Literature

Functional implications of the conformational landscape of a multidrug transporter revealed by Zebrafish Abcb4 structures.

Zhan, J.Hsieh, C.M.Esser, L.Lang, Z.C.Morton, A.J.Robey, R.Zhou, F.Ambudkar, S.V.Huang, R.K.Gottesman, M.M.Xia, D.

(2026) Nat Commun 

  • DOI: https://doi.org/10.1038/s41467-026-73751-4
  • Primary Citation Related Structures: 
    9ODY, 9ODZ, 9OE0, 9OE1, 9OE2, 9OE4, 9OE5, 9OE6, 9OE7, 9OE8, 9OE9

  • PubMed Abstract: 

    The hallmark of multidrug resistance conferred by the human ABC transporter ABCB1 (hP-gp) is the recognition and efflux of a diverse range of drugs, though the precise mechanism of polyspecificity remains unresolved. In aquatic animals such as zebrafish, Abcb4, a functional homolog of hP-gp, plays a vital role in surviving environmental toxicants. Here, we show that DrAbcb4 exhibits comparable basal and drug-stimulated ATPase activity to hP-gp. Using cryo-EM, we capture five inward-facing DrAbcb4 conformations with varying separations between its two lobes, illustrating its open-and-close motion. The range of separation exceeds that seen in published P-gp structures that appear to be conformationally restricted. This global open-and-close motion is coupled with individual helix movement, resulting in a highly fluid substrate-binding pocket. These dynamic changes, likely underlying the polyspecificity of substrate recognition, predict unconventional protein-ligand interactions that are supported by structures of DrAbcb4 bound to the P-gp inhibitors tariquidar and elacridar, and the substrate vincristine.


  • Organizational Affiliation
    • Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Macromolecule Content 

  • Total Structure Weight: 143.01 kDa 
  • Atom Count: 9,044 
  • Modeled Residue Count: 1,159 
  • Deposited Residue Count: 1,281 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
ATP-binding cassette, sub-family B (MDR/TAP), member 41,281Danio rerioMutation(s): 0 
Gene Names: abcb4zgc:172149
EC: 7.6.2.2
UniProt
Find proteins for E7F1E3 (Danio rerio)
Explore E7F1E3 
Go to UniProtKB:  E7F1E3
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupE7F1E3
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.16 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
MODEL REFINEMENTPHENIX1.21.2_5419
RECONSTRUCTIONcryoSPARC

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Cancer Institute (NIH/NCI)United States--

Revision History  (Full details and data files)

  • Version 1.0: 2026-06-03
    Type: Initial release
  • Version 1.1: 2026-06-10
    Changes: Data collection, Database references